Sep 29, 2021 - Sep 30, 2021 / NTS GMT
Spencer Israel - Benzinga - Media
All right. Let's bring David Elsley back on the stream there. He is once again President and CEO of Cardiol Therapeutics. David, long time no see.
David Elsley - Cardiol Therapeutics Inc. - President & CEO
Yes, nice to be back.
Spencer Israel - Benzinga - Media
Good to have you back. We have your slides here, guys. Let's bring them up on the screen. There they are. David I'm going to let you go more in-depth on Cardiol, and I will see myself out of here.
David Elsley - Cardiol Therapeutics Inc. - President & CEO
That's great. Good afternoon, everyone. It's a great pleasure to have the opportunity to introduce you to the work we're doing at Cardiol Therapeutics, where we are a heart failure-focused company. We're developing anti-inflammatory strategies for heart failure medicine. This is an area the Cardiol Therapeutics team has worked in now for over 30 years. I'm the founder, CEO and largest shareholder of Cardiol.
Cardiol Therapeutics Inc at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot